Stephens Investment Management Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
Stephens Investment Management Group's BEAT Position: Q1 2021 in Review
Stephens Investment Management Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 364,459 shares — an estimated $26.3M sold.
Stephens Investment Management Group first reported a position in BEAT in Q3 2018 and held it in 10 quarters. The position peaked at $47.8M in Q3 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Stephens Investment Management Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Stephens Investment Management Group sold 364,459 BioTelemetry, Inc. shares in Q1 2021, an estimated $26.3M.
- Stephens Investment Management Group first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 10 quarters.
- Stephens Investment Management Group's BioTelemetry, Inc. position peaked at $47.8M in Q3 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Stephens Investment Management Group's 13F filing for Q1 2021, filed 14 May 2021.